AI in Oncology: Current and Future Applications
AI has been used in oncology for years, but recent studies suggest AI could have many additional applications in cancer care.
Brain Cancer News
BRAIN CANCER ADVISOR
Brain Cancer News
Adverse Events Associated With Antibody-Drug Conjugates Across Cancer Types
Researchers say they have identified adverse events that are more likely to occur in cancer patients receiving antibody-drug conjugates.
Dabrafenib Plus Trametinib Bests Chemo in Kids With BRAF-Mutant Glioma
First-line treatment with dabrafenib and trametinib can improve outcomes, when compared to standard chemotherapy, in children with BRAFV600-mutated low-grade glioma, a phase 2 trial suggests.
Temozolomide Prescribing Information Updated Under FDA’s Project Renewal Program
Temozolomide is the second drug to receive a labeling update under Project Renewal.
Adding Ipilimumab to Nivolumab Doesn’t Provide Meaningful Benefit, Researchers Say
Adding ipilimumab to treatment with nivolumab does not provide a clinically meaningful benefit in patients with certain cancers, a meta-analysis suggests.
Dabrafenib Plus Trametinib Deemed Promising for BRAF-Mutant High-Grade Glioma
Dabrafenib plus trametinib can produce durable responses in pediatric patients with relapsed or refractory, BRAFV600-mutant high-grade glioma, a phase 2 trial suggests.
Some Studies Support Use of Cannabis in Pediatric Cancer; More Research is Needed
There is some evidence to support the use of cannabis for symptom management in children with cancer, but there is a lack of evidence on the safety and efficacy of cannabinoids in this patient population, according to researchers.
Mask Mandates Have Kept One Cancer Center Free From COVID-19. Others Have Lifted Masking Requirements Despite Patient Concerns
Some cancer centers have lifted mask mandates that were intended to protect patients from COVID-19, despite patient concerns.
Incidence of Early-Onset Cancers Increasing in the US
The incidence of early-onset cancers (diagnosed before age 50) has been increasing in recent years, according to a population-based study.
Cancer Survivors With Functional Disabilities Have Higher Health Care Costs
Cancer survivors with functional disabilities have higher health care usage and medical costs than survivors without disabilities, data suggest.
Birth Weight Linked to Risk of Certain Pediatric Cancers
Birth weight may be associated with the risk of certain pediatric cancers, a new study suggests.
Deaths Among Cancer Patients Increased During the First 2 Years of the COVID-19 Pandemic
Deaths in patients with COVID-19 and cancer made up 81% of excess deaths among cancer patients during the first 2 years of the pandemic.
Systemic Therapies May Increase Risk of VTE in Patients With Cancer and COVID-19
Researchers found a higher risk of VTE in patients with cancer and COVID-19 who were receiving systemic cancer therapies.
Medicare Limits Cancer Patients’ Access to Home Infusions. A New Bill Could Change That.
The Preserving Patient Access to Home Infusion Act could make home infusions more accessible, particularly for patients with cancer.
Lorazepam Use Linked to Shorter PFS, OS in Several Cancers
Lorazepam use may impact progression-free survival and overall survival in patients with a range of cancers, new research suggests.
Industry-Sponsored Cancer Trials More Likely to Have Consent Documents Translated
Industry-sponsored cancer trials are more likely to have consent documents translated to languages other than English, a study suggests.
Less Than Half of Cancer Trials Had Results Reported Within 1 Year of Completion
In an analysis of more than 10,000 cancer clinical trials, less than half had results reported within 1 year of trial completion.
Cancer Was Underdiagnosed in the First Year of the COVID-19 Pandemic
New research suggests that, in the United States, cancer was underdiagnosed during the first year of the COVID-19 pandemic.
Excessive Alcohol Consumption May Be Common in Cancer Patients, Survivors
Excessive alcohol consumption may be common among cancer survivors and cancer patients currently receiving treatment, a new study suggests.
With Twitter (Now X) in Flux, Is #MedTwitter Under Threat?
Oncology professionals share what #MedTwitter means to them and where they might go if Twitter (now X) becomes obsolete.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...